SCHEMBL1640767

SCHEMBL1640767

CC(=O)c1c(C)n[nH]c1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 1/20 0.59
DYRK1A Q13627 1/20 0.44
LMNA P02545 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.39
HCAR2 Q8TDS4 3/20 0.38
GAA P10253 1/20 0.37
HSD17B10 Q99714 1/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 1/20 0.36
DAO P14920 1/20 0.34
BRD4 O60885 1/20 0.34
BRPF1 P55201 1/20 0.34
CREBBP Q92793 1/20 0.34
CSNK2A2 P19784 2/20 0.34
KDR P35968 2/20 0.34
CSNK2B P67870 2/20 0.34
CSNK2A1 P68400 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1663754 0.81 PDE4D (0.59) PDE4DDYRK1ALMNAL3MBTL1CYP2C19
SCHEMBL15777023 0.79 PDE4D (0.57) PDE4DDYRK1ALMNAL3MBTL1CYP2C19
SCHEMBL23926008 0.79 PDE4D (0.57) PDE4DDYRK1ALMNAL3MBTL1CYP2C19
SCHEMBL10858885 0.76 PDE4D (0.63) PDE4DDYRK1ALMNAL3MBTL1CYP3A4
SCHEMBL352117 0.76 PDE4D (0.53) PDE4DDYRK1ALMNAL3MBTL1CYP2C19
SCHEMBL8006591 0.76 PDE4D (0.53) PDE4DDYRK1ALMNAL3MBTL1CYP1A2
SCHEMBL22678620 0.74 PDE4D (0.39) PDE4DLMNAL3MBTL1CYP1A2CYP3A4
SCHEMBL12106580 0.74 CYP1A2 (0.39) PDE4DL3MBTL1CYP1A2CYP3A4CYP2C19
SCHEMBL12106575 0.74 PDE4D (0.43) PDE4DLMNAL3MBTL1CYP1A2CYP3A4
SCHEMBL10839267 0.74 PDE4D (0.56) PDE4DDYRK1ALMNAL3MBTL1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100104644-A1 Compositions and Methods for Treating or Preventing Ophthalmic Disease UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2010-04-29 US claimed
US-20090291919-A1 Compositions and Methods for Treating or Preventing Ophthalmic Light Toxicity UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2009-11-26 US claimed
US-20090286808-A1 Opsin Stabilizing Compounds and Methods of Use UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2009-11-19 US claimed
EP-2069390-A2 OPSIN STABILIZING COMPOUNDS AND METHODS OF USE University of Florida Research Foundation, Inc. (US) 2009-06-17 EP claimed
WO-2008013986-A2 COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OPHTHALMIC LIGHT TOXICITY UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2008-01-31 WO claimed
WO-2008013983-A2 OPSIN STABILIZING COMPOUNDS AND METHODS OF USE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2008-01-31 WO claimed
US-4321395-A Preparation of acetanilides BASF AKTIENGESELLSCHAFT (DE) 1982-03-23 US claimed
US-20230065629-A1 SUBSTITUTED 6-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE DERIVATIVES AND USES THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-03-02 US disclosed
US-11208400-B2 Substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereof BAYER AKTIENGESELLSCHAFT (DE) 2021-12-28 US disclosed
EP-3526212-B1 SUBSTITUTED 6-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE DERIVATIVES AND USES THEREOF BAYER AG (DE) 2021-12-22 EP disclosed
WO-2021046179-A1 NOVEL COMPOUNDS INTRA-CELLULAR THERAPIES, INC. (US) 2021-03-11 WO disclosed
US-20200055842-A1 SUBSTITUTED 6-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE DERIVATIVES AND USES THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2020-02-20 US disclosed
US-8962551-B2 Quinoxalinyl derivatives ENANTA PHARMACEUTICALS, INC. (US) 2015-02-24 US disclosed
EP-0007588-B1 TETRAHYDRO-1,3-OXAZINES, HERBICIDAL COMPOSITIONS CONTAINING ACETANILIDES AS HERBICIDAL AGENTS AND SAID TETRAHYDRO-1,3-OXAZINES AS ANTAGONISTIC AGENTS, AND THEIR USE FOR COMBATING UNDESIRED PLANT GROWTH BASF Aktiengesellschaft (DE) 1981-05-13 EP disclosed
US-4249935-A Herbicidal agents BASF AKTIENGESELLSCHAFT (DE) 1981-02-10 US disclosed
EP-0014880-A1 Phenoxycarboxylic acid amides, process for their preparation and their use as herbicides BAYER AG (DE) 1980-09-03 EP disclosed
EP-0009091-A1 Process for selectively combating undesired plant growth with herbicidal agents comprising acetanilides and N-dichloroacetyl-2,2-dimethyl-1,3-oxazolidine BASF Aktiengesellschaft (DE) 1980-04-02 EP disclosed
EP-0008649-A1 Herbicidal agents comprising acetanilides and N-isopropyl-N-propargyl-dichloracetamide and process for selectively combating undesired plant growth BASF Aktiengesellschaft (DE) 1980-03-19 EP disclosed
EP-0007575-A1 Herbicidal compositions based on acetanilides and their use in combating undesired plant growth BASF Aktiengesellschaft (DE) 1980-02-06 EP disclosed
EP-0007588-A1 Tetrahydro-1,3-oxazines, herbicidal compositions containing acetanilides as herbicidal agents and said tetrahydro-1,3-oxazines as antagonistic agents, and their use for combating undesired plant growth BASF Aktiengesellschaft (DE) 1980-02-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291919-A1 Compositions and Methods for Treating or Preventing Ophthalmic Light Toxicity ALDH1A2, EYA3, PDE6C PDE4D 490/4885DYRK1A 4837/4885LMNA 1092/4885
US-11208400-B2 Substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereof REN, ATP6V1B1, GLS PDE4D 725/4885DYRK1A 4572/4885LMNA 206/4885
US-20100104644-A1 Compositions and Methods for Treating or Preventing Ophthalmic Disease ALDH1A2, PDE6C, EYA3 PDE4D 320/4885DYRK1A 4850/4885LMNA 979/4885
US-20090286808-A1 Opsin Stabilizing Compounds and Methods of Use CRYZ, NR2E3, CRYAB PDE4D 1075/4885DYRK1A 4495/4885LMNA 1096/4885
US-20200055842-A1 SUBSTITUTED 6-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE DERIVATIVES AND USES THEREOF REN, ATP6V1B1, GLS PDE4D 725/4885DYRK1A 4572/4885LMNA 206/4885
US-20230065629-A1 SUBSTITUTED 6-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE DERIVATIVES AND USES THEREOF REN, ATP6V1B1, GLS PDE4D 725/4885DYRK1A 4572/4885LMNA 206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.